SCHEMBL11901043

SCHEMBL11901043

Cc1cccc(-c2ccnc(N)c2N)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP4K4 O95819 3/20 0.48
▸ KDR P35968 3/20 0.48
▸ ADORA1 P30542 3/20 0.48
▸ LRRK2 Q5S007 2/20 0.48
▸ CHEK1 O14757 1/20 0.48
▸ ABL1 P00519 1/20 0.48
▸ NTRK1 P04629 1/20 0.48
▸ LCK P06239 1/20 0.48
▸ FYN P06241 1/20 0.48
▸ CSF1R P07333 1/20 0.48
▸ MET P08581 1/20 0.48
▸ PDGFRB P09619 1/20 0.48
▸ PIM1 P11309 1/20 0.48
▸ FGFR1 P11362 1/20 0.48
▸ PDGFRA P16234 1/20 0.48
▸ PRKACA P17612 1/20 0.48
▸ LTK P29376 1/20 0.48
▸ GRK5 P34947 1/20 0.48
▸ FLT3 P36888 1/20 0.48
▸ MAPK8 P45983 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4582784 0.81 MAP4K4 (0.69) MAP4K4KDRADORA1LRRK2CHEK1
SCHEMBL12100759 0.81 MAP4K4 (0.46) MAP4K4PRKACAGSK3BMAP2K1NOS3
SCHEMBL17555726 0.79 FYN (0.49) MAP4K4FYNPIM1PRKACAGSK3B
SCHEMBL23319557 0.79 MAP4K4 (0.45) MAP4K4ADORA1RAB9ANOS3NOS2
SCHEMBL11902083 0.79 MAP4K4 (0.56) MAP4K4KDRADORA1LRRK2ABL1
SCHEMBL4938505 0.79 DYRK1A (0.54) MAP4K4ADORA1LRRK2ABL1FYN
SCHEMBL11158123 0.79 RAB9A (0.43) MAP4K4KDRADORA1LRRK2CHEK1
SCHEMBL11821346 0.79 KMO (0.51) MAP4K4KDRADORA1LRRK2CHEK1
SCHEMBL13730604 0.78 NOS3 (0.52) MAP4K4KDRLRRK2GSK3BAURKB
SCHEMBL1165179 0.77 GSK3B (0.47) MAP4K4KDRADORA1LRRK2CHEK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11600791-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-03-07 — — US disclosed
EP-3936512-A1 PYRIDYL CARBENE PHOSPHORESCENT EMITTERS Universal Display Corporation (US) 2022-01-12 — — EP disclosed
EP-3424935-B1 IMIDAZOPYRAZINYL CARBENE PHOSPHORESCENT EMITTERS UNIVERSAL DISPLAY CORP (US) 2021-08-11 — — EP disclosed
US-20210050530-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2021-02-18 — — US disclosed
US-10873038-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2020-12-22 — — US disclosed
US-20190109287-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2019-04-11 — — US disclosed
EP-3424935-A1 PYRIDYL CARBENE PHOSPHORESCENT EMITTERS Universal Display Corporation (US) 2019-01-09 — — EP disclosed
EP-2683728-B1 IRIDIUM COMPLEXES WITH 3-PHENYL-3H-IMIDAZO[4,5-b]PYRIDINE, 3-PHENYL-3H-IMIDAZO[4,5-b]PYRAZINE AND 1-PHENYL-3H-IMIDAZO[4,5-b]PYRIDINE CARBENE LIGANDS USED AS PHOSPHORESCENT EMITTERS IN ORGANIC LIGHT EMITTING DEVICES UNIVERSAL DISPLAY CORP (US) 2018-09-05 — — EP disclosed
US-9972793-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2018-05-15 — — US disclosed
CN-103476767-B Heterocyclic compounds as PI3 kinase inhibitors HOFFMANN LA ROCHE 2015-06-10 — — CN disclosed
US-20150021590-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2015-01-22 — — US disclosed
US-8883322-B2 Pyridyl carbene phosphorescent emitters UNIVERSAL DISPLAY CORPORATION (US) 2014-11-11 — — US disclosed
US-8653089-B2 Heterocyclic compounds and methods of use F. HOFFMANN-LA ROCHE AG (CH) 2014-02-18 — — US disclosed
EP-2683728-A2 PYRIDYL CARBENE PHOSPHORESCENT EMITTERS Universal Display Corporation (US) 2014-01-15 — — EP disclosed
EP-2673269-A1 HETEROCYCLIC COMPOUNDS AS PI3 KINASE INHIBITORS F.HOFFMANN-LA ROCHE AG (CH) 2013-12-18 — — EP disclosed
US-20120228583-A1 PYRIDYL CARBENE PHOSPHORESCENT EMITTERS UNIVERSAL DISPLAY CORPORATION (US) 2012-09-13 — — US disclosed
WO-2012121936-A2 PYRIDYL CARBENE PHOSPHORESCENT EMITTERS UNIVERSAL DISPLAY CORPORATION (US) 2012-09-13 — — WO disclosed
WO-2012107465-A1 HETEROCYCLIC COMPOUNDS AS PI3 KINASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2012-08-16 — — WO disclosed
US-20120202785-A1 HETEROCYCLIC COMPOUNDS AND METHODS OF USE F. HOFFMANN-LA ROCHE AG (CH) 2012-08-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210050530-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES NUDC, NCL, NDC1 MAP4K4 2876/4885KDR 1040/4885ADORA1 3679/4885
US-10873038-B2 Organic electroluminescent materials and devices NUDC, NCL, NDC1 MAP4K4 2876/4885KDR 1040/4885ADORA1 3679/4885
US-20120202785-A1 HETEROCYCLIC COMPOUNDS AND METHODS OF USE PIK3CA, PIK3CD, AKT3 MAP4K4 191/4885KDR 1959/4885ADORA1 2558/4885
US-20120228583-A1 PYRIDYL CARBENE PHOSPHORESCENT EMITTERS PAICS, PIR, NUDC MAP4K4 2758/4885KDR 835/4885ADORA1 2146/4885
US-20190109287-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES NUDC, NCL, NDC1 MAP4K4 2876/4885KDR 1040/4885ADORA1 3679/4885
US-11600791-B2 Organic electroluminescent materials and devices NUDC, NCL, NDC1 MAP4K4 2876/4885KDR 1040/4885ADORA1 3679/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback